Evidence map›Paper›PMID 33874801›Full record

ArticleAIDS care2022

Awareness, acceptability, and intention to initiate HIV pre-exposure prophylaxis among pregnant women.

Rachel K Scott, Shawnika J Hull, Robin C Richards, Kristen Klemmer, Frida Salmoran, Jim C Huang

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Rachel K ScottWomen's Health Research, MedStar Health Research Institute (MHRI), Washington, DC, USA.
Shawnika J HullSchool of Communication & Information, Rutgers University, New Brunswick, NJ, USA.
Robin C RichardsWomen's & Infants' Services, MedStar Washington Hospital Center (MWHC), Washington, DC, USA.
Kristen KlemmerObstetrics & Gynecology, Georgetown University School of Medicine (GUSOM), Washington, DC, USA.
Frida SalmoranWomen's Health Research, MedStar Health Research Institute (MHRI), Washington, DC, USA.
Jim C HuangWomen's Health Research, MedStar Health Research Institute (MHRI), Washington, DC, USA.
Georgetown University · USMedStar Health · USMedStar Washington Hospital Center · USRutgers, The State University of New Jersey · US

Funding

Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
Substance Use and HIV Prevention Research in Minority Communities Training ProgramR25DA028567 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Julia Lechuga, Torsten Brian Neilands · 2009 to 2026
$5.4M
Sisters Informing Sisters about Topics on AIDS and Prevention (SISTA-P): Adaptation of the SISTA intervention to include PrEP information and skills building for Black women who are risk for HIVK01DA050496 · NIDA · RUTGERS, THE STATE UNIV OF N.J. · PI HULL, SHAWNIKA J · 2020 to 2023
$696k
NCATS NIH HHS UL1 TR001409NIDA NIH HHS K01 DA050496NIDA NIH HHS R25 DA028567
6 · The paper itself

Abstract

HIV prevention is critically important during pregnancy, however, pre-exposure prophylaxis (PrEP) is underutilized. We conducted a survey of pregnant and non-pregnant women in a high HIV prevalence community in Washington D.C. to evaluate determinants of PrEP initiation during pregnancy. 201 pregnant women and a reference population of 1103 non-pregnant women completed the survey. Among pregnant women, mean age was 26.9 years; the majority were Black with household-incomes below the federal poverty level. Despite low perceived risk of HIV acquisition and low prior awareness of PrEP, 10.5% of respondents planned to initiate PrEP during pregnancy. Pregnant women identified safety, efficacy, and social network and medical provider support as key factors in PrEP uptake intention. The belief that PrEP will "protect (their) baby from HIV" was associated with PrEP uptake intention during pregnancy. Concerns regarding maternal/fetal side effects, and safety in pregnancy or while breastfeeding were not identified as deterrents to uptake intention. When compared to a nonpregnant sample, there were no significant differences in uptake intention between the two samples. These findings support the need for prenatal educational interventions to promote HIV prevention during pregnancy, as well as interventions that center on the role of providers in the provision of PrEP.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdultBreast FeedingFemaleHumansIntentionPregnancyPregnant PeopleAnti-HIV AgentsBehavioral intentionhigh prevalenceHIV preventionHuman Immunodeficiency Virus (HIV)Integrated Model of Behavior Predictionpre-exposure prophylaxis (PrEP)pregnancypsychosocial determinantsreasoned action approachwomen

Identifiers

PMID33874801
PMCPMC8523573
OpenAlexW3153551364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.